Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy.

[1]  A. Moss,et al.  Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry) , 2015, Circulation.

[2]  J. Daubert,et al.  Smarter deployment of implantable cardioverter-defibrillators in nonischemic cardiomyopathy: feasible or mythical? , 2014, Journal of the American College of Cardiology.

[3]  A. Kadish,et al.  Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[4]  Marco Merlo,et al.  Long‐term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years , 2014, European journal of heart failure.

[5]  G. Heinze,et al.  Confidence intervals after multiple imputation: combining profile likelihood information from logistic regressions , 2013, Statistics in medicine.

[6]  G. Barbati,et al.  Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis , 2013, Circulation.

[7]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[8]  Suraj Khanal.  How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with “SCD-HeFT Criteria?” , 2013 .

[9]  V. Thohan,et al.  Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2. , 2012, Journal of cardiac failure.

[10]  D. Rosenbaum,et al.  Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction. , 2012, The American journal of cardiology.

[11]  Mark E. Anderson,et al.  Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.

[12]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[13]  H. Kestler,et al.  Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy , 2009, European heart journal.

[14]  Arturo Evangelista,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  A. Keren,et al.  [Classification of the cardiomyopathies]. , 2008, Kardiologia polska.

[16]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[17]  A. Kadish,et al.  Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.

[18]  Daniel B. Mark,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure , 2005 .

[19]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[20]  A. Khasnis,et al.  Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy , 2004 .

[21]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[22]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[23]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[24]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[25]  L. Mestroni,et al.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. , 1999, European heart journal.